The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells

The only currently available approach to early efficacy testing of tuberculosis (TB) vaccine candidates is in vivo preclinical challenge models. These typically include mice, guinea pigs and non-human primates (NHPs), which must be exposed to virulent M.tb in a ‘challenge’ experiment following vacci...

書誌詳細
主要な著者:	Tanner, R, Hoogkamer, E, Bitencourt, J, White, A, Boot, C, Sombroek, CC, Harris, SA, O'Shea, MK, Wright, D, Wittenberg, R, Sarfas, C, Satti, I, Verreck, FAW, Sharpe, SA, Fletcher, HA, McShane, H
フォーマット:	Journal article
言語:	English
出版事項:	F1000Research 2021

類似資料

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
著者:: Tanner, R, 等
出版事項: (2021)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
著者:: Rachel Tanner, 等
出版事項: (2021-01-01)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
著者:: Pepponi, I, 等
出版事項: (2017)

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
著者:: Brennan, M, 等
出版事項: (2017)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
著者:: Tanner, R, 等
出版事項: (2020)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
著者:: Tanner, R, 等
出版事項: (2021)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
著者:: Painter, H, 等
出版事項: (2024)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
著者:: Harris, S, 等
出版事項: (2017)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
著者:: Mcshane, H, 等
出版事項: (2017)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
著者:: Marsay, L, 等
出版事項: (2013)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
著者:: Alvarez, MPP, 等
出版事項: (2024)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
著者:: Marsay, L, 等
出版事項: (2013)

Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes
著者:: Naranbhai, V, 等
出版事項: (2015)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
著者:: O'Shea, M, 等
出版事項: (2018)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
著者:: Marco Polo Peralta Alvarez, 等
出版事項: (2024-05-01)

A review of clinical models for the evaluation of human TB vaccines.
著者:: O'Shea, M, 等
出版事項: (2016)

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients
著者:: Ongarj, J, 等
出版事項: (2024)

Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates
著者:: Tanner, R
出版事項: (2015)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
著者:: Tanner, R, 等
出版事項: (2017)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
著者:: Matsumiya, M, 等
出版事項: (2014)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
著者:: Meyer, J, 等
出版事項: (2013)

Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination
著者:: Bitencourt, J, 等
出版事項: (2021)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
著者:: Meyer, J, 等
出版事項: (2013)

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
著者:: Peralta-Álvarez, MP, 等
出版事項: (2024)

Cytomegalovirus infection is a risk factor for TB disease in infants
著者:: Müller, J, 等
出版事項: (2019)

The characterisation of mycobacterial control profiles and underlying immune signatures in patients with latent tuberculosis infection and active disease
著者:: O'Shea, M
出版事項: (2016)

Glycomimetic inhibitors of mycobacterial glycosyltransferases: targeting the TB cell wall.
著者:: Lucas, R, 等
出版事項: (2008)

Non-TB mycobacterial infections in patients with non-CF bronchiectasis
著者:: M Mirsaeidi, 等
出版事項: (2015-01-01)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
著者:: McNeill, E, 等
出版事項: (2018)

Quantitative Rapid Test for Detection and Monitoring of Active Pulmonary Tuberculosis in Nonhuman Primates
著者:: Zijie Zhou, 等
出版事項: (2021-12-01)

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection
著者:: Matthew K. O'Shea, 等
出版事項: (2018-12-01)

Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection
著者:: O'Shea, M, 等
出版事項: (2018)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
著者:: Painter, H, 等
出版事項: (2024)

Using aerosol Bacille Calmette-Guérin in non-human primates to model the immune response to Mycobacterium Tuberculosis: a translational bridge between preclinical models and clinical trials
著者:: Hoogkamer, E
出版事項: (2022)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
著者:: Hannah Painter, 等
出版事項: (2024-02-01)

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults
著者:: Riste, M, 等
出版事項: (2021)

Risk factors for atypical mycobacterial disease in patients with smear positive pulmonary TB
著者:: Hany Shaarawy, 等
出版事項: (2014-07-01)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
著者:: Thomas, Z, 等
出版事項: (2014)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
著者:: Fletcher, H, 等
出版事項: (2013)

The fall of the mycobacterial cell wall: interrogating peptidoglycan synthesis for novel anti-TB agents
著者:: Cheng-Yu Chiang, 等
出版事項: (2024-11-01)